Search Results

Part 4 - II Gen TKI as I line in every CML patient in India - Dr K Govind Babu, Bengaluru

Part 4 - II Gen TKI as I line in every CML patient in India - Dr K Govind Babu, Bengaluru

Part 5- Patients with newly diagnosed CML-CP in India should receive 2nd Gen TKIs- Dr Dinesh Bhurani

Part 5- Patients with newly diagnosed CML-CP in India should receive 2nd Gen TKIs- Dr Dinesh Bhurani

Upfront 2nd generation TKI in CML: G. Saglio

Upfront 2nd generation TKI in CML: G. Saglio

Current status of third-line therapy for CML

Current status of third-line therapy for CML

Part 8 - Panel Discussion: Treating CML in India - Practical Considerations - Dr Hemant Malhotra

Part 8 - Panel Discussion: Treating CML in India - Practical Considerations - Dr Hemant Malhotra

Part 7 - Treatment Free Remission (TFR) in CML : Status Update - Dr Hari Menon, Bengaluru

Part 7 - Treatment Free Remission (TFR) in CML : Status Update - Dr Hari Menon, Bengaluru

$Refractory CML Swami Iyer$

Refractory CML Swami Iyer

Managing CML in emerging regions: some problems and perspectives

Managing CML in emerging regions: some problems and perspectives

Changing Paradigm in Management of CML in India

Changing Paradigm in Management of CML in India

What are the newer options for patients who fail first- and second-generation TKI therapies?

What are the newer options for patients who fail first- and second-generation TKI therapies?

If diagnosed early it is treatable...

If diagnosed early it is treatable...

Part 2 - What's new in the 2020 ELN guidelines? - Dr Tulika Seth, Delhi

Part 2 - What's new in the 2020 ELN guidelines? - Dr Tulika Seth, Delhi